Delivery Order SPE2DR25D6028-SPE2DR26FAULK
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Naloxone 2mg/2ml in quantities of 10 units, with a ceiling value of $3,593.26. This is a firm fixed-price delivery order with an ultimate completion date of January 5, 2026, and represents performance at the contractor's Conshohocken, Pennsylvania location. This award was not designated as a set-aside contract and was competitively awarded through open competition,...
- The Defense Logistics Agency awarded a $2,311.22 delivery order to AmerisourceBergen Drug Corp for naloxone 0.4 mg/ml vials, with an ultimate completion date of December 23, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,835.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes. This competitive, firm fixed-price contract was awarded on January 20, 2026, with an ultimate completion date of January 21, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed on a full and open basis among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,595.87 to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials. The contract, awarded on November 10, 2025, carries a firm fixed price structure with an ultimate completion date of November 12, 2025. The award represents a competitive procurement with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,554.28. This is a firm fixed-price delivery order with an ultimate completion date of November 5, 2025, and carries no set-aside designation, indicating it was awarded through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This competitively awarded, firm fixed-price delivery order has a ceiling value of $2,053.07 and an ultimate completion date of August 25, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Naloxone 0.4 mg/mL vials, valued at $1,385.79, with an ultimate completion date of January 15, 2026. This non-set-aside, firm fixed-price delivery order was competitively awarded on January 14, 2026, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare...
- The U.S. Defense Department's Medical Supply Chain awarded a $16,048.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Naloxone 2mg/2mL (10-pack units) on July 28, 2025, with completion targeted for August 22, 2025. The award was competitively procured with no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 3, 2025, for the supply of Naloxone 1mg/ml in quantities of 10 units. This contract, valued at $21,543.97, carries a firm fixed price and is scheduled for completion by April 30, 2025. The award was made through open competition with no set-aside designation, leveraging AmerisourceBergen's established capacity as a critical pharmaceutical distributor for federal medical...
- SPE2DR25D6028Indefinite Delivery Contract
- SPE2DR25D6028-SPE2DR26FAULKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 2mg/2ml (10 units) under a firm fixed-price contract valued at $18,723.10. The delivery order was issued on January 28, 2026, with an ultimate completion date of February 25, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award was made on a non-set-aside, competitive basis, reflecting the contractor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent company, Cencora, Inc. (doing business as AmerisourceBergen), holds a comprehensive IDC with the Defense Logistics Agency covering a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs globally. As a critical pharmaceutical distributor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio delivering medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||